Press release
Biopharma PEG to Present PEG Derivatives at TIDES USA 2026 in Boston
The event will be held at the Hynes Convention Center in Boston, Massachusetts, USA, from May 11-14, 2026. Biopharma PEG will welcome visitors at Booth 826 to discuss product selection, application needs, and supply support for research and development projects.
PEG derivatives are widely used in pharmaceutical and biotechnology research because they can improve solubility, support stability, and provide flexible conjugation options. In recent years, they have played an important role in the development of lipid nanoparticles, ADCs, PROTACs, polymer-drug conjugates, click chemistry, and surface modification. As these fields continue to grow, reliable PEG materials remain essential for both early-stage research and larger-scale development.
Biopharma PEG offers a broad selection of monodispersed PEGs, polydispersed PEGs, and multi-arm PEGs, along with a variety of functional groups including azide, amine, maleimide, thiol, DSPE, and NHS ester. These products are designed to support a wide range of research and conjugation strategies across drug discovery and formulation development.
"Our team looks forward to meeting attendees at Booth 826 and discussing how our PEG products can support their research goals," said Sonia Lee of Biopharma PEG. "We welcome the opportunity to connect with scientists and industry professionals working in drug delivery and bioconjugation."
Biopharma PEG provides more than 5,000 PEG derivatives and supports projects from early R&D through GMP commercial supply. The company serves research and development needs in pharmaceutical science, advanced delivery systems, and bioconjugation workflows.
Featured product categories include:
Polydispersed PEGs (M.W. 200-43 KDa)
mPEG-PALD (DMF/CDE), HZ-PEG-HZ(DMF), OH-PEG-AA, DSPE-PEG-Mannose, DSPE-PEG-NH2, Y-Shape-PEG-NHS, 4-ArmPEG-SG, 4-ArmPEG-SH
Monodispersed PEGs (Units 1-48)
mPEG36-NH2, OH-PEG9-OH, OH-PEG6-COOH, N3-PEG11-NH2, N3-PEG3-SPA, N3-PEG3-COOH, NH2-PEG3-OH, NH2-PEG8-CH2CH2COOtBu
Website: www.biochempeg.com
Email: sales@biochempeg.com
Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050
Fax: 617-206-9595
Email: sales@biochempeg.com
Biopharma PEG is a supplier of high-purity PEG derivatives for pharmaceutical research and development. The company offers a broad portfolio of PEG products for applications in drug delivery, ADC development, PROTAC research, lipid nanoparticles, chemical biology, and bioconjugation.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharma PEG to Present PEG Derivatives at TIDES USA 2026 in Boston here
News-ID: 4496179 • Views: …
More Releases from Biopharma PEG Scientific Inc
Biopharma PEG Offers In-Stock Monodispersed PEGs at Competitive Prices
Biopharma PEG Scientific Inc. announced the availability of a broad range of in-stock monodispersed PEG derivatives at highly competitive prices, supporting researchers working in antibody-drug conjugates (ADCs), nanoparticle and LNP delivery systems, diagnostics, and biomaterials.
Biopharma PEG specializes in PEG derivatives, including monodispersed, polydispersed, and multi-arm PEGs, offered in both GMP and non-GMP grades. By keeping key monodispersed PEGs on the shelf and ready to ship, the company aims to help…
Biopharma PEG Highlights the Critical Role of PEG-Lipid Nanoparticles in RNA The …
Watertown, MA, September 26, 2025 - In the past decade, lipid nanoparticles (LNPs) have emerged as the premier delivery vehicle for RNA-based medicines, powering the success of both siRNA drugs and mRNA vaccines. A key component of these systems is PEG-lipids, specialized polyethylene glycol (PEG) derivatives that stabilize nanoparticles, extend circulation time, and enhance safety.
Why PEG-Lipids Are Essential
RNA molecules are inherently unstable in the bloodstream, where they are rapidly degraded…
BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database.
mPEG-pALD (20K) - DMF No. 040600
HZ-PEG-HZ (1K) - DMF No. 041864
These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the…
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,…
More Releases for USA
Remote Team Online Collaboration Tools Market Size in 2023 To 2029 | Asana (USA) …
The global market for Remote Team Online Collaboration Tools is anticipated to achieve a value of US$ million by 2029, experiencing growth from the US$ million recorded in 2022. This expansion is projected to be fueled by a compounded annual growth rate (CAGR) of % during the timeframe spanning from 2023 to 2029. Notable factors influencing the market, including economic conditions, the impacts of COVID-19, and the Russia-Ukraine War, have…
Risk Analysis Management Market 2019: By FireMon (USA), ForcePoint (USA), HPE De …
This report studies the Risk Analysis Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Risk Analysis Management market by product type and applications/end industries.
The global Risk Analysis Management market is valued at xx million USD in 2017 and is expected to reach xx million USD by…
Global Medical Wearable Market to 2025| Abbott Laboratories(USA), MC10(USA), Med …
Researchmoz added Most up-to-date research on "Global Medical Wearable Market Insights, Forecast to 2025" to its huge collection of research reports.
The global Medical Wearable market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Medical Wearable market based on company,…
AFCC Debt Settlement Market Outlook to 2023 – National Debt Relief (USA),Rescu …
According to this study, over the next five years the AFCC Debt Settlement market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in AFCC Debt Settlement business This report presents a comprehensive overview, market shares and growth opportunities of…
Global Wearables in Healthcare Market to 2025: Abbott Laboratories(USA), MC10(US …
Researchmoz added Most up-to-date research on "Global Wearables in Healthcare Market Insights, Forecast to 2025" to its huge collection of research reports.
The global Wearables in Healthcare market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Wearables in Healthcare…
Risk Analysis Management Market Outlook to 2023 – FireMon (USA), ForcePoint (U …
Risk and Vulnerability Analysis – including the ability to create virtual network maps and visualize network connections and analyze traffic flow
In this report, Publisher studies the present scenario (with the base year being 2017) and the growth prospects of global Risk Analysis Management market for 2018-2023.
Request for Sample of Global Risk Analysis Management Market 2018 Research Report: https://www.researchreportsinc.com/sample-request?id=232759
Over the next five years, Publisher projects that Risk Analysis Management will…
